Managing pulmonary edema.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001815:Bloodletting; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004070:Digitalis / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000209:etiology; D003932:Heroin / Q000009:adverse effects; D006760:Hospitalization; D006801:Humans; D007362:Intensive Care Units; D008944:Mitral Valve Insufficiency / Q000150:complications; D008946:Mitral Valve Stenosis / Q000150:complications; D009020:Morphine / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011175:Positive-Pressure Respiration; D011187:Posture; D011654:Pulmonary Edema / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D012121:Respiration, Artificial; D014111:Tourniquets; D014690:Venous Pressure
D000959:Antihypertensive Agents; D001993:Bronchodilator Agents; D003932:Heroin; D004077:Digoxin; D009020:Morphine; D005665:Furosemide